menu
    • menu

    Company profile for IDRx

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. Inspired by a few curative combination regimens in cancer and the successful drug cocktails purposely engineered in other disease areas such as cystic fibrosis and antivirals, IDRx aims to address the limitations of today’s precision cancer medicines with highly -selective, pur...
    IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. Inspired by a few curative combination regimens in cancer and the successful drug cocktails purposely engineered in other disease areas such as cystic fibrosis and antivirals, IDRx aims to address the limitations of today’s precision cancer medicines with highly -selective, purposely -designed drug combinations to help more patients achieve prolonged, durable responses to therapy earlier in the course of their disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IDRxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Plymouth, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.idrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/idrx/about/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GSK to buy US biotech firm IDRx for up to $1.15 billion
    GSK to buy US biotech firm IDRx for up to $1.15 billion

    14 Jan 2025

    // PRESS RELEASE

    https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-idrx-inc/

    PRESS RELEASE
    14 Jan 2025
    Share Share
    IDRx Updates Phase 1 Data for IDRX-42 in GIST at CTOS 2024
    IDRx Updates Phase 1 Data for IDRX-42 in GIST at CTOS 2024

    14 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241113773722/en

    BUSINESSWIRE
    14 Nov 2024
    Share Share
    IDRx Announces $120M Series B Financing For GIST Treatment Development
    IDRx Announces $120M Series B Financing For GIST Treatment Development

    07 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240806631982/en

    BUSINESSWIRE
    07 Aug 2024
    Share Share
    IDRx's IDRX-42 Shows Best-In-Class Potential In GIST Phase 1 Data
    IDRx's IDRX-42 Shows Best-In-Class Potential In GIST Phase 1 Data

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240531639390/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share
    IDRx Appoints David P. Kerstein, M.D., as Chief Medical Officer
    IDRx Appoints David P. Kerstein, M.D., as Chief Medical Officer

    27 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240326917518/en

    BUSINESSWIRE
    27 Mar 2024
    Share Share
    IDRx Strengthens Executive Team
    IDRx Strengthens Executive Team

    12 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240312469762/en

    BUSINESSWIRE
    12 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search